Clinical treatment (non surgical) of spasticity in cerebral palsy;Tratamiento clínico (no quirúrgico) de la espasticidad en la parálisis cerebral

Revista de Neurologia

Volumn 34, Issue 1, 2002, Pages 1-6

  Calderón González, Raúl ^a   Calderon Sepulveda R F ^a  

^a Ctro Neurologico para Ninos y Adol   (Mexico)

Author keywords

Antispastic pharmacotherapy; Botulinum toxin; Cerebral palsy Phenol inyections; Rehabilitation; Spasticity

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BACLOFEN; BOTULINUM TOXIN; DANTROLENE; DIAZEPAM; PHENOL; TIZANIDINE; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

BIOMECHANICS; CEREBRAL PALSY; CHILD; CONFERENCE PAPER; DENERVATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; EFFERENT NERVE; HUMAN; NERVE CELL EXCITABILITY; ORTHOSIS; SPASTICITY; PATHOPHYSIOLOGY; REHABILITATION; REVIEW;

BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; DENERVATION; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; REHABILITATION;

EID: 2242465683     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3401.2001298     Document Type: Conference Paper

References (47)

1. Terminology and classification of cerebral palsy
2. Spasticity
3. Cerebral palsy: Clinical diagnosis and natural history
4. The changing panorama of cerebral palsy: Bilateral spastic forms in particular
5. Spasticity management: An overview
6. Spasticity: A review
7. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion
8. Cerebral palsy
9. Management of spasticity in spinal cord injury
10. Physical therapy interventions for patients with movement disorders due to cerebral palsy
11. General rehabilitation
12. Consensus conference on efficacy of physical therapy in the management of cerebral palsy
13. Efficacy of a neuro-developmental treatment program to improve motor control in infants born prematurely
14. Early physical therapy in the treatment of spastic diplegia
15. Physical management of spasticity
16. The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia
17. Psychological stress in mothers of disabled children
18. A randomized controlled trial of early physiotherapy for high-risk infants
19. Early intervention for children with or at risk of cerebral palsy
20. A randomized controlled trial of different intensities of physiotherapy and different goal-settings procedures in 44 children with cerebral palsy
21. Antispasticity medications
22. Current issues in spasticity management
23. Pharmacotherapy of spasticity: Oral medications and intrathecal baclofen
24. A controlled trial of baclofen in children with cerebral palsy
25. Tizanidine: A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
26. Efficacy and safety of tizanidine in the treatment of spasticity
27. Comparative profile of tizanidine in the management of spasticity
28. Summary of combined clinical analysis of controlled clinical trials with tizanidine
29. Antispastic drugs: Mechanisms of action
30. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments
31. Evaluation and treatment of spasticity
32. Dantroleno sodium: A review of its pharmacological properties and therapeutic efficacy in spasticity
33. Treatment of spasticity
34. The effects of medications that reduce spasticity in the management of spastic cerebral palsy
35. Traditional pharmacological treatments for spasticity. Part I: Local treatments
36. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
37. Botulinum toxin in the management of the lower limb in cerebral palsy
38. Botulinum toxin type A treatment of cerebral palsy: An integrated approach
39. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo controlled trial
40. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy
41. Clinical utility of botulinum toxin in the treatment of cerebral palsy: Comprehensive review
42. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
43. Experimental botulism in monkeys: A clinical pathological study
44. Management of spasticity in cerebral palsy with botulinum toxin: Report of a preliminary, randomized, double-blind trial
45. Botulinum toxin in the management of the lower limb in cerebral palsy
46. Botulinum toxin A in management of cerebral palsy
47. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomized prospective trial